Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers
暂无分享,去创建一个
Caroline Jung | D. Torpy | W. Inder | John G Lewis | J. Ho | Warrick J Inder | Jui T Ho | David J Torpy | Santo Greco | Hanh HT Nguyen | C. Jung | J. Lewis | S. Greco | H. H. Nguyen
[1] A. Iranmanesh,et al. Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. , 1993, The Journal of clinical endocrinology and metabolism.
[2] G. Besser,et al. Endocrine and metabolic diseases. Adrenal diseases. , 1976, British medical journal.
[3] J. Ratcliffe,et al. PATTERNS OF PLASMA CORTISOL AND ACTH CONCENTRATIONS IN PATIENTS WITH ADDISON'S DISEASE TREATED WITH CONVENTIONAL CORTICOSTEROID REPLACEMENT , 1981, Clinical endocrinology.
[4] Jayne Holme,et al. An evaluation of measured and calculated serum free cortisol in a group of patients with known adrenal suppression , 2010, Annals of clinical biochemistry.
[5] W. Inder,et al. Management of adrenal insufficiency during the stress of medical illness and surgery , 2008, The Medical journal of Australia.
[6] R. Dullaart,et al. The daily cortisol production reinvestigated in healthy men. The serum and urinary cortisol production rates are not significantly different. , 1998, The Journal of clinical endocrinology and metabolism.
[7] H. Kehlet,et al. GLUCOCORTICOID MAINTENANCE THERAPY FOLLOWING ADRENALECTOMY: ASSESSMENT OF DOSAGE AND PREPARATION , 1976, Clinical endocrinology.
[8] W. Burch. Urine free-cortisol determination. A useful tool in the management of chronic hypoadrenal states. , 1982, JAMA.
[9] S. Tunn,et al. Simultaneous measurement of cortisol in serum and saliva after different forms of cortisol administration. , 1992, Clinical chemistry.
[10] R. Eastell,et al. Glucocorticoid replacement therapy: are patients over treated and does it matter? , 1997, Clinical endocrinology.
[11] M. Debono,et al. Modified-release hydrocortisone to provide circadian cortisol profiles. , 2009, The Journal of clinical endocrinology and metabolism.
[12] L. Behan,et al. Optimizing glucocorticoid replacement therapy in severely adrenocorticotropin‐deficient hypopituitary male patients , 2011, Clinical endocrinology.
[13] S. Lightman,et al. Why is the management of glucocorticoid deficiency still controversial: a review of the literature , 2005, Clinical endocrinology.
[14] M. Mclean,et al. Saliva and bloodspot cortisol: novel sampling methods to assess hydrocortisone replacement therapy in hypoadrenal patients , 2004, Clinical endocrinology.
[15] S. Aanderud,et al. Plasma cortisol concentrations after oral substitution of cortisone in the fasting and non-fasting state. , 2009, Acta medica Scandinavica.
[16] V. Wright,et al. Endocrine disorders , 1991, Current opinion in rheumatology.
[17] M. J. Chapman,et al. Septic shock and sepsis: a comparison of total and free plasma cortisol levels. , 2006, The Journal of clinical endocrinology and metabolism.
[18] Zaki K Hassan-Smith,et al. 11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess , 2014, Proceedings of the National Academy of Sciences.
[19] D. Freedman,et al. Evidence for the Low Dose Dexamethasone Suppression Test to Screen for Cushing's Syndrome—Recommendations for a Protocol for Biochemistry Laboratories , 1997, Annals of clinical biochemistry.
[20] G. Tucker,et al. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia , 2006, Clinical endocrinology.
[21] M. Zwahlen,et al. Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma. , 2012, The Journal of clinical endocrinology and metabolism.
[22] J. Puder,et al. Cortisol response in relation to the severity of stress and illness. , 2005, The Journal of clinical endocrinology and metabolism.
[23] G. Tucker,et al. Modified‐release hydrocortisone for circadian therapy: a proof‐of‐principle study in dexamethasone‐suppressed normal volunteers , 2008, Clinical endocrinology.
[24] R. Clayton,et al. ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. , 2009, The Journal of clinical endocrinology and metabolism.
[25] D. Scott. Chapter 10 – Endocrine and Metabolic Diseases , 2001 .
[26] E. Aardal,et al. Cortisol in Saliva - Reference Ranges and Relation to Cortisol in Serum , 1995, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.
[27] V. Montori,et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. , 2008, The Journal of clinical endocrinology and metabolism.
[28] T. Howlett. An Assessment of Optimal Hydrocortisone Replacement Therapy , 1997, Clinical endocrinology.
[29] J. Connell,et al. Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to Patients with adrenal insufficiency , 2007, Clinical endocrinology.
[30] G. R. Cannell,et al. Plasma cortisol delivery from oral cortisol and cortisone acetate: relative bioavailability. , 1984, British journal of clinical pharmacology.
[31] M. Mclean,et al. The clinical utility of alternative, less invasive sampling techniques in the assessment of oral hydrocortisone therapy in children and adolescents with hypopituitarism. , 2007, European journal of endocrinology.
[32] C. Migeon,et al. Cortisol production rate. II. Normal infants, children, and adults. , 1966, Pediatrics.
[33] K. Løvås,et al. Saliva cortisol measurement: Simple and reliable assessment of the glucocorticoid replacement therapy in Addison’s disease , 2006, Journal of endocrinological investigation.
[34] E. Lentjes,et al. Salivary Cortisol day curves in assessing glucocorticoid replacement therapy in Addison’s disease , 2013, Hormones.
[35] Kristian Løvås,et al. Continuous subcutaneous hydrocortisone infusion in Addison's disease. , 2007, European journal of endocrinology.
[36] S. Hahner,et al. Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements , 2006, Clinical endocrinology.
[37] T. Hedner,et al. Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study. , 2009, European journal of endocrinology.
[38] S. Lightman,et al. Subcutaneous pulsatile glucocorticoid replacement therapy , 2014, Clinical endocrinology.
[39] R. Carey,et al. Adrenal insufficiency. , 1997, Current therapy in endocrinology and metabolism.
[40] J L Coolens,et al. Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. , 1987, Journal of steroid biochemistry.
[41] A. Yergey,et al. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. , 1991, The Journal of clinical endocrinology and metabolism.
[42] A. Rostami-Hodjegan,et al. Weight‐related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency , 2004, Clinical endocrinology.
[43] B. Arafah. Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods. , 2006, The Journal of clinical endocrinology and metabolism.
[44] M. Debono,et al. Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy. , 2009, European journal of endocrinology.
[45] R. Murray,et al. European Adrenal Insufficiency Registry (EU-AIR): a comparative observational study of glucocorticoid replacement therapy , 2014, BMC Endocrine Disorders.